Binding induced folding in p53-MDM2 complex

被引:112
|
作者
Chen, Hai-Feng [1 ]
Luo, Ray [1 ]
机构
[1] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
关键词
D O I
10.1021/ja0678774
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The MDM2 N-terminal domain can bind to the transactivation domain of p53 and downregulate its ability to activate transcription. It was found that binding with p53 stabilizes the MDM2 N-terminal domain. Thus the coupling between binding and folding is essential in the normal functional interactions between p53 and MDM2. We have performed explicit-solvent molecular dynamics simulations (MD) for both bound MDM2(N) and apo-MDM2 to study the interdependence of binding and folding in the p53-MDM2 complex. Kinetic analysis of high-temperature MD simulations shows that both bound MDM2N and apo-MDM2 unfold via a two-state process. Both kinetics and free energy landscape analyses indicate that bound MDM2 unfolds in the order of p53 unbinding, tertiary unfolding, and finally secondary structure unfolding. Our data show that the unfolding pathways are different between bound MDM2N and apo-MDM2: the unfolding order of unstable helices and tertiary contacts is reversed. Transition state analysis shows that the transition state of bound MDM2 is more nativelike and more heterogeneous than that of apo-MDM2. The predicted Phi- values suggest that the stable helices are more nativelike than other regions in both bound MDM2N and apo-MDM2. Within the stable helices, helix II in bound MDM2 is more nativelike than that in apo-MDM2. However, helix I and IV in bound MDM2 are less nativelike than those in apo-MDM2.
引用
收藏
页码:2930 / 2937
页数:8
相关论文
共 50 条
  • [1] Binding induced folding in p53-MDM2 complex
    Chen, Hai-Feng
    Luo, Ray
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 331 - 331
  • [2] Molecular simulation of the p53-MDM2 binding interface
    Pantelopulos, George A.
    Voelz, Vincent A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [3] Pharmacophore model construction of p53-MDM2 binding inhibitors
    Sheng Rong
    Hu Chun-Qi
    Huang Wen-Hai
    Hu Yong-Zhou
    ACTA PHYSICO-CHIMICA SINICA, 2007, 23 (11) : 1815 - 1820
  • [4] Combination therapy with p53-MDM2 binding inhibitors for malignancies
    Jin, Zegao
    Shen, Jianfeng
    He, Jingyao
    Hu, Chunqi
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (04) : 1369 - 1379
  • [5] Evolution of the p53-MDM2 pathway
    Emma Åberg
    Fulvio Saccoccia
    Manfred Grabherr
    Wai Ying Josefin Ore
    Per Jemth
    Greta Hultqvist
    BMC Evolutionary Biology, 17
  • [6] Evolution of the p53-MDM2 pathway
    Aberg, Emma
    Saccoccia, Fulvio
    Grabherr, Manfred
    Ore, Wai Ying Josefin
    Jemth, Per
    Hultqvist, Greta
    BMC EVOLUTIONARY BIOLOGY, 2017, 17
  • [7] p53-MDM2 and MDMX Antagonists
    Neochoritis, Constantinos
    Estrada-Ortiz, Natalia
    Khoury, Kareem
    Domling, Alexander
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 167 - 187
  • [8] Elevated MDM2 contributes to antitumor activity of p53-MDM2 binding inhibitors
    Xia, Mingxuan
    Knezevic, Dejan
    Tovar, Christian
    Heimbrook, David C.
    Vassilev, Lyubomir T.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3616S - 3616S
  • [9] Effect of Nutlin-3a on stability of p53-MDM2 complex
    Zhou, Han
    Geng, Yi-Zhao
    Yan, Shi-Wei
    ACTA PHYSICA SINICA, 2023, 72 (06)
  • [10] Computational studies and peptidomimetic design for the human p53-MDM2 complex
    Zhong, HZ
    Carlson, HA
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 58 (01) : 222 - 234